MORE THAN JUST PATIENT’S
European association taking the interests of European pALS
EupALS is an European association taking the interests of European pALS (ALS patients) to heart. We thus want to create equal rights for all the European pALS and provide better access to research and information about it.
MISSION
Aiming to unite all the European ALS associations…
… to fight harder together on a European scale
Stand up for the rights of all the European pALS
Create awareness on a European scale
Improve access to & information about research
Create the same rules for ALS research across Europe xxxxx
29
MEMBER
ASSOCIATIONS
ARTICLES & ADVICE
Checkout our most recent Articles And Insights on ALS
-
VectorY Therapeutics Receives FDA Clearance of IND to Proceed with the PIONEER-ALS Phase 1/2 Trial of VTx-002, a First-in-Class Vectorized Antibody Targeting TDP-43 Pathology in ALS
|
VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced that the U.S. Food and Drug Administration (FDA) has cleared the company to proceed with the PIONEER-ALS Phase… More u003eu003e
-
NeuroSense Receives FDA Clearance to Initiate Pivotal Phase 3 Trial for PrimeC in ALS
|
NeuroSense Therapeutics, a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, announced that the U.S. Food and Drug Administration (FDA) has completed the review of the Investigational… More u003eu003e
-
Collaborative Partnership between IQVIA and TRICALS
|
Amyotrophic Lateral Sclerosis (ALS), also known as motor neurone disease (MND) or Lou Gehrig’s Disease (LGD) in the US, is a progressive neurodegenerative disease. Although relatively rare, with 2 new… More u003eu003e
-
IONIS ALS community statement on completion of enrollment of FUSION clinical trial of ulefnersen
|
Dear ALS/MND Community, We are writing to inform you that Ionis has completed enrollment of FUSION (NCT04768972), the pivotal Phase 3 clinical trial of our investigational medicine, ulefnersen (ION363). FUSION… More u003eu003e
15+
AWARD ACHIEVED
50k+
SATISFIED PATIENTS
750+
Hospitals Room
450+
Qualified Doctors & Staff
